Kiora Pharmaceuticals Inc filed 2 current reports with the SEC under Item 5.02, which covers directors and officers leaving or being appointed, the latest on 2026-09-08. Between them they name 1 person. Each change below is quoted from the filing and linked to it.
Every change, newest first
Appointed: Keith Lane, Executive Vice President, Head
On September 8, 2026 (the "Effective Date"), Kiora Pharmaceuticals Inc. (the "Company") appointed Keith Lane as Executive Vice President, Head of Clinical Development and Regulatory Affairs of the Company, effective as of the Effective Date.
Reported
On April 1, 2026, Eric J. Daniels, M.D., MBA, the Chief Development Officer of Kiora Pharmaceuticals, Inc. (the "Company"), notified the Company that he will resign as Chief Development Officer effective as of April 17, 2026 (the "Effective Date") to pursue another opportunity.
Find people with the same kind of experience as the Executive Vice President, Head at Kiora Pharmaceuticals Inc, with the record behind each one.
Find candidates like Head at Kiora Pharmaceuticals IncNew leaders review vendors and budgets in their first months. Get an alert the next time Kiora Pharmaceuticals Inc is in the news or changes leadership.
Get an alert when Kiora Pharmaceuticals Inc changes leadershipTools for this story
Each opens in a new tab, filled in for Kiora Pharmaceuticals Inc. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.